BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30968715)

  • 21. Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects.
    Xu L; Zhang Y; Tian K; Chen X; Zhang R; Mu X; Wu Y; Wang D; Wang S; Liu F; Wang T; Zhang J; Liu S; Zhang Y; Tu C; Liu H
    J Exp Clin Cancer Res; 2018 Oct; 37(1):261. PubMed ID: 30373602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
    Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
    Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
    Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
    Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
    J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
    Sorrentino C; Miele L; Porta A; Pinto A; Morello S
    Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways.
    Matsuoka H; Tsubaki M; Yamazoe Y; Ogaki M; Satou T; Itoh T; Kusunoki T; Nishida S
    Exp Cell Res; 2009 Jul; 315(12):2022-32. PubMed ID: 19393235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined blockade of Tim-3 and MEK inhibitor enhances the efficacy against melanoma.
    Liu Y; Cai P; Wang N; Zhang Q; Chen F; Shi L; Zhang Y; Wang L; Hu L
    Biochem Biophys Res Commun; 2017 Mar; 484(2):378-384. PubMed ID: 28132803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine-like molecule CCDC134 contributes to CD8⁺ T-cell effector functions in cancer immunotherapy.
    Huang J; Xiao L; Gong X; Shao W; Yin Y; Liao Q; Meng Y; Zhang Y; Ma D; Qiu X
    Cancer Res; 2014 Oct; 74(20):5734-45. PubMed ID: 25125657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway.
    Prasad P; Vasas A; Hohmann J; Bishayee A; Sinha D
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
    Nagai H; Hara I; Horikawa T; Oka M; Kamidono S; Ichihashi M
    J Invest Dermatol; 2000 Dec; 115(6):1059-64. PubMed ID: 11121142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells.
    Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA
    J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
    Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forsythiae Fructus Inhibits B16 Melanoma Growth Involving MAPKs/Nrf2/HO-1 Mediated Anti-Oxidation and Anti-Inflammation.
    Bao J; Ding R; Zou L; Zhang C; Wang K; Liu F; Li P; Chen M; Wan JB; Su H; Wang Y; He C
    Am J Chin Med; 2016; 44(5):1043-61. PubMed ID: 27430915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Simulated weightlessness inhibits antitumor immunity of T lymphocytes in melanoma-bearing mice].
    Si S; Song S; Shi L; Liu J; Xu B; Yi Y; Tan X; Zhang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):127-31. PubMed ID: 23388329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells.
    Kou Y; Li L; Li H; Tan Y; Li B; Wang K; Du B
    Biochem Biophys Res Commun; 2016 Oct; 479(2):290-296. PubMed ID: 27639645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.
    del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI
    Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Co-stimulation of multiple activating factors on proliferation and phenotype of T lymphocytes in peripheral blood in vitro].
    Liu JQ; Zhu Y; Chen FX; Zhang NZ; Lv XT; Zhou ZH; Zhang J; Zhang S; Tao ZZ; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):367-70. PubMed ID: 22482405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells.
    Kato Y; Yoshino I; Egusa C; Maeda T; Pili R; Tsuboi R
    J Dermatol Sci; 2014 Aug; 75(2):140-7. PubMed ID: 24866536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR4 is critically involved in effective antitumor immunity in mice bearing intradermal B16 melanoma.
    Matsuo K; Itoh T; Koyama A; Imamura R; Kawai S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
    Cancer Lett; 2016 Aug; 378(1):16-22. PubMed ID: 27132989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.